XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
GE shareholders' equity balance
Accumulated other comprehensive income (loss)
Currency translation adjustments
Benefit plans
Investment securities and cash flow hedges
Long-duration insurance contracts
Other capital
Retained earnings
Common stock held in treasury
Noncontrolling interest
Beginning balance at Dec. 31, 2021     $ (4,860)     $ 5,172 $ (9,109) $ 34,691 $ 83,286 $ (81,093)  
Increase (decrease) in shareholders' equity                      
Other comprehensive income (loss)       $ (177) $ 238 (2,998) 3,682        
Purchases                   (39)  
Dispositions               (396)   459  
Stock-based compensation               91      
Other changes [1]               5      
Net earnings (loss) attributable to the Company $ (1,136)               (1,136)    
Dividends and other transactions with shareholders [2]                 (141)    
Ending balance at Mar. 31, 2022 32,909 $ 31,631 (4,115) (4,746) 3,884 2,174 (5,427) 34,391 82,009 (80,673) $ 1,278
Preferred stock issued 6                    
Common stock issued 15                    
Preferred stock issued 6                    
Common stock issued 15                    
Beginning balance at Dec. 31, 2022 34,912   (2,272)     (1,927) (983) 34,173 82,983 (81,209)  
Increase (decrease) in shareholders' equity                      
Other comprehensive income (loss)       2,388 (2,317) 706 (1,793)        
Purchases               3,000   (311)  
Dispositions               (619)   759  
Stock-based compensation               73      
Other changes [1]               (2,898)      
Net earnings (loss) attributable to the Company 7,506               7,506    
Dividends and other transactions with shareholders [2]                 (5,534)    
Ending balance at Mar. 31, 2023 32,823 $ 31,652 $ (3,289) $ (3,505) $ 4,214 $ (1,222) $ (2,776) $ 30,729 $ 84,955 $ (80,762) $ 1,171
Preferred stock issued 3                    
Common stock issued $ 15                    
[1] Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.
[2] Included $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.